Why is this having a meltdown so close to results??

O.T. Yodeling is now out...

Charlie Bilello (@charliebilello) Tweeted:
Second wave of covid-19 in Europe continues w/ surge in new cases in some countries...
-Ex: new daily high of 8,737 cases in Switzerland today is equivalent to 335k cases in the US (population adjusted). Yodeling concert there is said to have been a superspreader event. https://t.co/1AY7J3wjpJ

Second wave of covid-19 in Europe continues w/ surge in new cases in some countries...
-Ex: new daily high of 8,737 cases in Switzerland today is equivalent to 335k cases in the US (population adjusted). Yodeling concert there is said to have been a superspreader event. pic.twitter.com/1AY7J3wjpJ

— Charlie Bilello (@charliebilello) October 20, 2020

Tomorrow at 8 PM is the grand Hummer EV reveal.

UP TO
1,000
HORSEPOWER†
UP TO
11,500 LB-FT
OF TORQUE†
0-60 MPH
IN
3 SECONDS†

GM is spending a small fortune in launching this vehicle and Mary is betting the farm. It just has to be a hit.

Slim, LN is a subset of Lupus.. AUPH is only for LN and not Lupus..

This is not a big market..

You mean overhype, Jess?

They will perform a reverse split I expect..

$22.60 share price in 1.5 years. This is the most probable, realistic analysis...

Aurinia is well-capitalized at $264M despite the non-partnership developmental process they have employed. Analysts expect 2021 revenues from Voclosporin sales of $93M (7.9% market share).
Aurinia's next catalyst is in 4Q 2020 when VOS's Phase 2/3 for DES will publish its Phase 2/3 results.
In summary, with Voclosporin's NDA submitted for the $1.1B LN market, cash for commercialization, and expected sales in 2021, AUPH is a "buy" at a 1.5-year price target of $22.69 (+45% upside).

Tesla debt close to an investment grade rating after a S&P upgrade.

https://on.mktw.net/3jVwCZx P- Tesla’s debt close to investment grade after S&P upgrade

What a Monster in the making..

ILJIN is at it again selling shares. Not many. See filings tonight..

The fade. Cannot catch a break..

Awarding a new employee 10,000 options when first hired seems very generous, and dilutes the heck out of existing shareholders. I find it to be more prudent to award options to employees AFTER one year of employment. Some leave or are fired before that first year is over..

Aurinia has a recruiting problem, as they are hiring 9 new individuals and providing each one with 10,000 stock options as they walk in the door. WallStreet hates this>>>>>

VICTORIA, British Columbia--(BUSINESS WIRE)--October 2, 2020--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that the Company’s Compensation
Committee granted 9 new employees non-qualified stock options to purchase an aggregate of 96,000 common shares, at a per share exercise price of $14.73 USD, the closing trading price on September 30, 2020. One-third of the options vest in October 2021, and the balance of the options vests in a series of 24 equal monthly installments thereafter. The inducement options were granted as an inducement material to the new employees entering into employment with Aurinia in accordance with Nasdaq Listing Rule 5635(c)(4). For the purposes of TSX approval, the Company relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible inter-listed issuers on a recognized exchange, such as Nasdaq.
The inducement stock options also have a ten year term and are subject to the terms and conditions of the stock option agreement pursuant to which the option was granted.”

What about the existing employees??

Sweet bite, my azz...

It's Time to take a sweet bite: Aurinia Pharmaceuticals Inc. (AUPH), Pioneer Natural Resources ...
BOV News

If Exxon is still awake, they need to cut the dividend in 2020 so the the majority of the bad news remains in 2020 and they can start fresh in 2021.

Cowen:" $AUPH survey with expert rheumatologists: nearly all (88%) of surveyed clinicians believe that there is not a sufficient treatment option for LN, with voclosporin selected as the most promising drug candidate=market sizing of roughly 100,000+ LN patients; TP=$30."

Cowen:" $AUPH survey with expert rheumatologists: nearly all (88%) of surveyed clinicians believe that there is not a sufficient treatment option for LN, with voclosporin selected as the most promising drug candidate=market sizing of roughly 100,000+ LN patients; TP=$30."

— Tom Silver (@TomSilver39) September 29, 2020

I expect that is what is holding the price back. This is a difficult disease to treat, and investors are cautious as there are many that tried and failed..

Oil is collapsing again. Exxon needs to consider partnering with Tesla and offer a 100 share certificate of XOM stock to every new Tesla buyer as a reminder of what oil was....

Cervelo, there positively will be no dilution until after approval. Then, let it rip...

Looks like a yawn. I expected a little more fire..

CLF, at first glance, I thought wow Goncales is going to own N America steel, but, page 17 of the presentation gives me pause.. CLF is investing $1.3 billion for MT in cash, preferred stock, and common stock, and they receiving $1.4 billion in pension liabilities and a steel company..

WBA needs to be removed from the S&P index

ALB getting kicked to the curb on TSLA’s decision to begin to obtain some of their lithium by their own mining. Maybe over reaction..

Market is looking like 1999 again. It will hit everything

I expect it is too late.....

Well, that was fun...

Why so weak?

Wish I bought PUTS. Crappy action. I was hoping this doesn’t become an AMRN. That is a board of depression.

Why Albertsons Is a Buy: More Meals at Home and the Stock Is Cheap https://www.barrons.com/articles/why-albertsons-is-a-buy-more-meals-at-home-and-the-stock-is-cheap-51600467478?st=qpzu4e3dougjbmc

Talk about Negative Nelly:

BP expects lower world GDP, energy consumption and oil demand for decades because of the economic effects of Covid-19.
#OOTT #oilandgas #oil #WTI #CrudeOil #fintwit #OPEC

pic.twitter.com/Gg22vkJSvw

Art Berman
@aeberman12


9/16/20, 3:27 PM

I’ve been following this for two years and there really hasn’t been much clinical progress, but a WHOLE lot of new stock issued. If this really had the technical value you claim, this would have been taken out by now. Good luck.

Anyone hear from North? He put his heart and soul into researching this company and probably lost a fortune as he road it all the way up and then all the way down. Hope he is OK..

Huge buyback by ACI announced this morning. With the new CEO a highly talented exec from Pepsi, we have room to run. Working and consuming from home is the new norm.

Wow, you called him everything in the book and he responded. Canadian culture..

Slim, your chance of a reply are pretty remote. I expect you know that..

Jim Grant on Cliffs:


https://www.grantspub.com/almostDailyHTML.cfm?dcid=718&article=1&email=tom%2Eflorida%40gmail%2Ecom

I always read Jim’s colorful pieces..

Surprised there wasn't a glimmer of a bounce. There should have been one, imo...

Entered a position yesterday. Rrecognized seller exhaustion..

Aurina stock performance has been lack luster since the May 1st $18.xx peak. Down trend from that peak.. Even with robust DES results, I'm Suspicious to what value creation that does for the stock.

It's not covid or cancer.. Mr. Market needs or can embrace only one or two biotech themes at a time.

I tend to agree with this author on the value of DES in this market..


joel menkes
Comments (9.89K)
Yesterday, 9:32 AM

"Third, even FDA approved DES drugs are not always free of suspicion."
"The market currently seems to ignore most of its DES pipeline value."
For the top one, these days the fda has earned distrust of anything it does. Deservedly so imo. For the bottom one, seems to me the market currently largely ignores most non-covid developments.
It'll be nice to get back to normal or as close to it as possible. Thanks for the article.